203 related articles for article (PubMed ID: 36243827)
1. Efficacy of methylphenidate for the treatment of apathy in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled studies.
Lee CW; Chen JY; Ko CC; Chuang MH; Tsai WW; Sun CK; Hung KC
Psychopharmacology (Berl); 2022 Dec; 239(12):3743-3753. PubMed ID: 36243827
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for apathy in Alzheimer's disease.
Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
Rosenberg PB; Lanctôt KL; Drye LT; Herrmann N; Scherer RW; Bachman DL; Mintzer JE; ADMET Investigators
J Clin Psychiatry; 2013 Aug; 74(8):810-6. PubMed ID: 24021498
[TBL] [Abstract][Full Text] [Related]
4. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.
Scherer RW; Drye L; Mintzer J; Lanctôt K; Rosenberg P; Herrmann N; Padala P; Brawman-Mintzer O; Burke W; Craft S; Lerner AJ; Levey A; Porsteinsson A; van Dyck CH;
Trials; 2018 Jan; 19(1):46. PubMed ID: 29347996
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ
Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120
[TBL] [Abstract][Full Text] [Related]
6. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.
Mintzer J; Lanctôt KL; Scherer RW; Rosenberg PB; Herrmann N; van Dyck CH; Padala PR; Brawman-Mintzer O; Porsteinsson AP; Lerner AJ; Craft S; Levey AI; Burke W; Perin J; Shade D;
JAMA Neurol; 2021 Nov; 78(11):1324-1332. PubMed ID: 34570180
[TBL] [Abstract][Full Text] [Related]
7. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
Lanctôt KL; Scherer RW; Li A; Vieira D; Coulibaly H; Rosenberg PB; Herrmann N; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Burke WJ; Mintzer JE
Am J Geriatr Psychiatry; 2021 Jan; 29(1):81-89. PubMed ID: 32565008
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease.
Andrade C
J Clin Psychiatry; 2022 Feb; 83(1):. PubMed ID: 35120284
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of neuromodulation for apathy in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials.
Jin Y; Li J; Xiao B
J Psychiatr Res; 2024 Mar; 171():17-24. PubMed ID: 38237255
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.
Lanctôt KL; Rivet L; Tumati S; Perin J; Sankhe K; Vieira D; Mintzer J; Rosenberg PB; Shade D; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey AI; Padala KP; Herrmann N
Am J Geriatr Psychiatry; 2023 Dec; 31(12):1077-1087. PubMed ID: 37385898
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Kishi T; Sakuma K; Iwata N
Pharmacopsychiatry; 2020 Apr; 53(3):109-114. PubMed ID: 32000270
[TBL] [Abstract][Full Text] [Related]
12. Rivastigmine for Alzheimer's disease.
Birks JS; Grimley Evans J
Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
[TBL] [Abstract][Full Text] [Related]
13. Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.
Lanctôt KL; Chau SA; Herrmann N; Drye LT; Rosenberg PB; Scherer RW; Black SE; Vaidya V; Bachman DL; Mintzer JE
Int Psychogeriatr; 2014 Feb; 26(2):239-46. PubMed ID: 24169147
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.
Clark ED; Perin J; Herrmann N; Brawman-Mintzer O; Lanctôt KL; Lerner AJ; Mintzer J; Padala PR; Rosenberg PB; Sami S; Shade DM; van Dyck CH; Porsteinsson AP;
Alzheimers Dement (N Y); 2023; 9(3):e12403. PubMed ID: 37538343
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial).
Zeng L; Perin J; Gross AL; Shade D; Lanctôt KL; Lerner AJ; Mintzer JE; Brawman-Mintzer O; Padala PR; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Herrmann N; Rosenberg PB
Int J Geriatr Psychiatry; 2024 Jun; 39(6):e6108. PubMed ID: 38858522
[TBL] [Abstract][Full Text] [Related]
16. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
van Dyck CH; Arnsten AFT; Padala PR; Brawman-Mintzer O; Lerner AJ; Porsteinsson AP; Scherer RW; Levey AI; Herrmann N; Jamil N; Mintzer JE; Lanctôt KL; Rosenberg PB
Am J Geriatr Psychiatry; 2021 Jan; 29(1):51-62. PubMed ID: 32461027
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Transcranial Direct Current Stimulation Combined with Cognitive Training in the Treatment of Apathy in Patients with Alzheimer's Disease: Study Protocol for a Randomized Trial.
Nguyen JP; Boutoleau-Bretonniere C; Lefaucheur JP; Suarez A; Gaillard H; Chapelet G; Abad S; Van Langhenhove A; Nizard J; de Decker L
Rev Recent Clin Trials; 2018; 13(4):319-327. PubMed ID: 29658441
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids for the treatment of dementia.
Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
